UBVUX
Price
$75.79
Change
-$5.29 (-6.52%)
Updated
Apr 3 closing price
Net Assets
9.83B
VSCAX
Price
$20.55
Change
-$1.97 (-8.75%)
Updated
Apr 3 closing price
Net Assets
6.34B
Ad is loading...

UBVUX vs VSCAX

Header iconUBVUX vs VSCAX Comparison
Open Charts UBVUX vs VSCAXBanner chart's image
Undiscovered Managers Behavioral Val R4
Price$75.79
Change-$5.29 (-6.52%)
VolumeN/A
Net Assets9.83B
Invesco Small Cap Value A
Price$20.55
Change-$1.97 (-8.75%)
VolumeN/A
Net Assets6.34B
UBVUX vs VSCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
UBVUX vs. VSCAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UBVUX is a Hold and VSCAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
UBVUX has more cash in the bank: 9.83B vs. VSCAX (6.35B). UBVUX pays higher dividends than VSCAX: UBVUX (1.75) vs VSCAX (0.37). UBVUX was incepted earlier than VSCAX: UBVUX (8 years) vs VSCAX (26 years). VSCAX (1.12) and UBVUX (1.11) have similar cost to investors . VSCAX is a more actively managed with annual turnover of: 40.00 vs. UBVUX (27.00). UBVUX has a lower initial minimum investment than VSCAX: UBVUX (0) vs VSCAX (1000). UBVUX annual gain was more profitable for investors over the last year : 0.26 vs. VSCAX (-1.20). VSCAX return over 5 years is better than : 216.20 vs. UBVUX (155.38).
UBVUXVSCAXUBVUX / VSCAX
Total Expense Ratio1.051.1294%
Annual Report Gross Expense Ratio1.111.1299%
Fund Existence8 years26 years-
Gain YTD-2.735-4.21165%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.83B6.35B155%
Annual Yield % from dividends1.750.37478%
Returns for 1 year0.26-1.20-22%
Returns for 3 years-2.0913.84-15%
Returns for 5 years155.38216.2072%
Returns for 10 yearsN/A9.77-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTTX12.85N/A
N/A
ICON Health and Information Tech Inv
BRXSX13.75N/A
N/A
MFS Blended Research Intl Eq R2
DGEYX20.42N/A
N/A
BNY Mellon Global Emerging Mkts - Y
GAOTX20.20N/A
N/A
JPMorgan Global Allocation R3
CBFFX36.62-0.68
-1.82%
American Funds Global Balanced 529F1